Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2010660541;60542;60543 chr2:178591409;178591408;178591407chr2:179456136;179456135;179456134
N2AB1846555618;55619;55620 chr2:178591409;178591408;178591407chr2:179456136;179456135;179456134
N2A1753852837;52838;52839 chr2:178591409;178591408;178591407chr2:179456136;179456135;179456134
N2B1104133346;33347;33348 chr2:178591409;178591408;178591407chr2:179456136;179456135;179456134
Novex-11116633721;33722;33723 chr2:178591409;178591408;178591407chr2:179456136;179456135;179456134
Novex-21123333922;33923;33924 chr2:178591409;178591408;178591407chr2:179456136;179456135;179456134
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCT
  • RefSeq wild type template codon: GGA
  • Domain: Ig-120
  • Domain position: 27
  • Structural Position: 42
  • Q(SASA): 0.5147
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/T rs1576103220 None 1.0 D 0.743 0.563 0.597732455086 gnomAD-4.0.0 6.85284E-07 None None None None I None 0 0 None 0 0 None 0 0 9.00281E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.9023 likely_pathogenic 0.965 pathogenic -0.549 Destabilizing 1.0 D 0.731 prob.delet. D 0.542693298 None None I
P/C 0.9924 likely_pathogenic 0.9979 pathogenic -0.628 Destabilizing 1.0 D 0.788 deleterious None None None None I
P/D 0.9855 likely_pathogenic 0.9946 pathogenic -0.523 Destabilizing 1.0 D 0.742 deleterious None None None None I
P/E 0.9815 likely_pathogenic 0.9939 pathogenic -0.645 Destabilizing 1.0 D 0.745 deleterious None None None None I
P/F 0.996 likely_pathogenic 0.999 pathogenic -0.815 Destabilizing 1.0 D 0.793 deleterious None None None None I
P/G 0.9729 likely_pathogenic 0.99 pathogenic -0.671 Destabilizing 1.0 D 0.738 prob.delet. None None None None I
P/H 0.9773 likely_pathogenic 0.993 pathogenic -0.265 Destabilizing 1.0 D 0.773 deleterious D 0.607367303 None None I
P/I 0.9755 likely_pathogenic 0.991 pathogenic -0.38 Destabilizing 1.0 D 0.79 deleterious None None None None I
P/K 0.9862 likely_pathogenic 0.9948 pathogenic -0.561 Destabilizing 1.0 D 0.743 deleterious None None None None I
P/L 0.9115 likely_pathogenic 0.9668 pathogenic -0.38 Destabilizing 1.0 D 0.747 deleterious D 0.598080717 None None I
P/M 0.9806 likely_pathogenic 0.9936 pathogenic -0.401 Destabilizing 1.0 D 0.775 deleterious None None None None I
P/N 0.9843 likely_pathogenic 0.9943 pathogenic -0.278 Destabilizing 1.0 D 0.757 deleterious None None None None I
P/Q 0.9743 likely_pathogenic 0.9922 pathogenic -0.546 Destabilizing 1.0 D 0.759 deleterious None None None None I
P/R 0.9667 likely_pathogenic 0.9875 pathogenic 0.001 Stabilizing 1.0 D 0.763 deleterious D 0.639234581 None None I
P/S 0.9633 likely_pathogenic 0.9887 pathogenic -0.589 Destabilizing 1.0 D 0.745 deleterious D 0.562923921 None None I
P/T 0.9242 likely_pathogenic 0.9749 pathogenic -0.617 Destabilizing 1.0 D 0.743 deleterious D 0.601856072 None None I
P/V 0.9546 likely_pathogenic 0.982 pathogenic -0.402 Destabilizing 1.0 D 0.743 deleterious None None None None I
P/W 0.9978 likely_pathogenic 0.9993 pathogenic -0.892 Destabilizing 1.0 D 0.793 deleterious None None None None I
P/Y 0.9947 likely_pathogenic 0.9985 pathogenic -0.605 Destabilizing 1.0 D 0.802 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.